Address: 1, Friesland Drive,
Longmeadow Business Estate,
Modderfontein, 1645,
South Afri,South Africa
Tel: +27 11 372 5000
Web: http://www.merck.co.za/en/index.html;jsessionid=3908AB8A572B0943DE66A547ED859FFF
Merck (Pty) Ltd South Africawho take care of sales, distribution and technical support of a broad range of pharmaceutical, consumer health care and chemical products. The company prides itself on having had representatives in South Africa for more than 100 years and have been registered as an entity in their own right for more than 40 years. The local company has inherited its values from the parent in Germany. These values; ‘Courage’, ‘Respect’, ‘Responsibility’, ‘Integrity’, ‘Transparency’ and ‘Achievement’ are the foundation and substance of everything they do.
Merck is a global pharmaceutical and chemical enterprise with around 40,000 employees in 67 countries. With the acquisition of Millipore in July 2010, a global leader in the life science tools market, revenues totaled around EUR 9.3 billion in 2010.
The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter products. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, food, pharmaceutical and biotech industries.
The operational business is managed under the umbrella of Merck KGaA headquartered in Darmstadt (Germany). Around 30% of the company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E. Merck KG.
Merck is the world’s oldest pharmaceutical and chemical company – its roots date back to 1668.
Pharmaceuticals
Merck Serono: Oncology, neurodegenerative diseases, fertility, endocrinology, autoimmune and inflammatory diseases, CardioMetabolic Care
Consumer Health Care: Everyday health protection, mobility, women’s and children’s health, cough and cold
Chemicals
Merck Millipore: Protein research assays and reagents, cell culture solutions and drug discovery services for biopharmaceutical companies as well as laboratory chemicals for research, analytical and hospital laboratories
Performance Materials: Liquid crystals for displays used in televisions, PCs and consumer electronics. LED and OLED materials for display, lighting, and photovoltaics, active ingredients as well as pigments for the cosmetics, paints and coatings industries
Medicines for Africa’s Lenias Hwenda argues that the success of the much-talked-about African Medicines Agency hinges on a critical mass of African national regulators achieving WHO Level 3 maturity status.…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
See our Cookie Privacy Policy Here
